DGOCX
Price
$27.97
Change
+$0.30 (+1.08%)
Updated
Oct 20 closing price
Net Assets
598.73M
VSTSX
Price
$317.21
Change
+$3.54 (+1.13%)
Updated
Oct 20 closing price
Net Assets
2.02T
Interact to see
Advertisement

DGOCX vs VSTSX

Header iconDGOCX vs VSTSX Comparison
Open Charts DGOCX vs VSTSXBanner chart's image
Davis Opportunity C
Price$27.97
Change+$0.30 (+1.08%)
VolumeN/A
Net Assets598.73M
Vanguard Total Stock Mkt Idx Instl Sel
Price$317.21
Change+$3.54 (+1.13%)
VolumeN/A
Net Assets2.02T
DGOCX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
DGOCX vs. VSTSX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGOCX is a Hold and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.02T vs. DGOCX (599M). VSTSX pays higher dividends than DGOCX: VSTSX (1.15) vs DGOCX (0.16). DGOCX was incepted earlier than VSTSX: DGOCX (28 years) vs VSTSX (9 years). DGOCX (1.76) is less costly to investors than VSTSX (0.01). DGOCX is a more actively managed with annual turnover of: 23.00 vs. VSTSX (2.00). DGOCX has a lower initial minimum investment than VSTSX: DGOCX (1000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 13.82 vs. DGOCX (-10.41). VSTSX return over 5 years is better than : 85.01 vs. DGOCX (7.18).
DGOCXVSTSXDGOCX / VSTSX
Total Expense Ratio1.750.0117,500%
Annual Report Gross Expense Ratio1.760.0117,600%
Fund Existence28 years9 years-
Gain YTD14.81313.029114%
Front LoadN/AN/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets599M2.02T0%
Annual Yield % from dividends0.161.1514%
Returns for 1 year-10.4113.82-75%
Returns for 3 years13.4976.1618%
Returns for 5 years7.1885.018%
Returns for 10 years-2.07N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INDP3.700.27
+7.87%
Indaptus Therapeutics Inc
APPN28.150.36
+1.30%
Appian Corp
IONS73.090.02
+0.03%
Ionis Pharmaceuticals
LGO1.29-0.03
-2.27%
Largo
FDMT9.84-0.25
-2.48%
4D Molecular Therapeutics